Novel oral medication muvalaplin lowers Lp(a) in a small international trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...
earth13 小时
Old drug now called a "magic pill" because it regrows hair and improves heart health
A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.
manilatimes16 小时
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at ...
Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...
Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational ...